Thomas Penn

Meridian Venture Partners LLC (MVP Capital Partners) is a private equity firm founded in 1985 by Robert E. Brown and Bob Brown. The firm is headquartered in Radnor, Pennsylvania.

Protedyne Corp. provides industrial-quality automation and data management services. It offers genome-based drug discovery equipment. The firm also provides automation systems that combine laboratory robotic hardware with a software infrastructure to ensure data management and process tracking. The company was founded by Stan Klein in June 2000 and is headquartered in Windsor, CT.

Boston Millennia Partners (BMP) is a private equity and venture capital subsidiary of Glen Ventures Management, Inc founded in 1997 by Dana Callow. The firm headquartered in Boston, Massachusetts.

Penn Venture Partners (Penn Venture Partners) is a private equity firm founded in 2002. The firm is headquartered in Harrisburg, Pennsylvania.

NanoHorizons, Inc. designs and manufactures advanced nanoscale silver additives. The firm manufactures advanced nanoparticles for integration in a broad range of consumer, commercial and industrial products to provide permanent, effective anti-bacterial, antifungal, antiviral and performance enhancing characteristics. The company was founded by Joseph D. Cuiffi, Stephen J. Fonash, Daniel Hayes and Ali Kaan Kalkan in 2002 and is headquartered in Bellefonte, PA.

ANI Pharmaceuticals, Inc. leader in the specialty pharmaceuticals industry, ANI Pharmaceuticals develops, manufactures and markets top quality prescription and over-the-counter pharmaceuticals, made in the U.S.A. In three facilities with combined manufacturing, packaging and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. The fully-cGMP qualified facilities boast state-of-the-art analytical and stability laboratories for ANI's rapidly expanding research and development program. With several ANDAs pending FDA approval, and in various stages of development, ANI is poised for tremendous growth in the months and years to come!